Purchase Price Allocations |
The allocation of the purchase price to assets and liabilities based upon fair value determinations was as follows:
|
|
|
|
|
|
|
|
Cash
|
|
$
|
11,088
|
Accounts receivable, net
|
|
|
718
|
Inventory
|
|
|
4,457
|
Other assets
|
|
|
2,617
|
Fixed assets
|
|
|
4,407
|
Intangible assets
|
|
|
20,300
|
Goodwill
|
|
|
1,125,036
|
Total assets acquired
|
|
|
1,168,623
|
Liabilities assumed
|
|
|
(458,123)
|
Net assets acquired
|
|
$
|
710,500
|
The purchase price consists of the following:
|
|
|
|
|
|
|
|
Common stock
|
|
$
|
710,500
|
Total purchase price
|
|
$
|
710,500
|
|
Pro Forma Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mobivity Holdings Corp.
|
Unaudited Pro Forma Condensed Consolidated Statement of Operations
|
Nine Months Ended September 30, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mobivity
|
|
Livelenz
|
|
Pro forma adjustments
|
|
|
Pro forma combined
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
3,335,080
|
|
$
|
187,059
|
|
$
|
-
|
|
|
$
|
3,522,139
|
Cost of revenues
|
|
|
820,455
|
|
|
59,230
|
|
|
-
|
|
|
|
879,685
|
Gross margin
|
|
|
2,514,625
|
|
|
127,829
|
|
|
-
|
|
|
|
2,642,454
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
3,276,384
|
|
|
64,297
|
|
|
-
|
|
|
|
3,340,681
|
Sales and marketing
|
|
|
2,895,748
|
|
|
191,180
|
|
|
-
|
|
|
|
3,086,928
|
Engineering, research, and development
|
|
|
584,978
|
|
|
-
|
|
|
-
|
|
|
|
584,978
|
Depreciation and amortization
|
|
|
243,998
|
|
|
2,819
|
|
|
-
|
|
|
|
246,817
|
Total operating expenses
|
|
|
7,001,108
|
|
|
258,296
|
|
|
-
|
|
|
|
7,259,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(4,486,483)
|
|
|
(130,467)
|
|
|
-
|
|
|
|
(4,616,950)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income/(expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
1,054
|
|
|
-
|
|
|
-
|
|
|
|
1,054
|
Interest expense
|
|
|
-
|
|
|
(31,658)
|
|
|
-
|
|
|
|
(31,658)
|
Change in fair value of derivative liabilities
|
|
|
34,980
|
|
|
-
|
|
|
-
|
|
|
|
34,980
|
Intangible asset impairment
|
|
|
(21,188)
|
|
|
-
|
|
|
-
|
|
|
|
(21,188)
|
Gain on adjustment in contingent consideration
|
|
|
89,740
|
|
|
|
|
|
|
|
|
|
89,740
|
Foreign Currency Gain/(Loss)
|
|
|
-
|
|
|
30,426
|
|
|
-
|
|
|
|
30,426
|
Total other income/(expense)
|
|
|
104,586
|
|
|
(1,232)
|
|
|
-
|
|
|
|
103,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(4,381,897)
|
|
|
(131,699)
|
|
|
-
|
|
|
|
(4,513,596)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(4,381,897)
|
|
$
|
(131,699)
|
|
$
|
-
|
|
|
$
|
(4,513,596)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share - basic and diluted
|
|
$
|
(0.17)
|
|
|
|
|
|
|
|
|
$
|
(0.17)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares
during the period - basic and diluted
|
|
|
25,973,592
|
|
|
|
|
|
|
|
|
|
25,973,592
|
|